Article Information
vol. 8 no. 2
Published By
Online ISSN
History
- Received October 1, 2021
- Accepted March 29, 2022
- Published online May 30, 2022.
Article Versions
- previous version (May 19, 2022 - 08:56).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright ©The authors 2022 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org
Author Information
- Oisín Butler1⇑,
- Shinyoung Ju1,
- Soeren Hoernig1,
- Kai Vogtländer2,
- Sameer Bansilal3 and
- Gustavo A. Heresi4
- 1Bayer AG, Berlin, Germany
- 2Medical Affairs Statistics, Bayer AG, Wuppertal, Germany
- 3Bayer HealthCare Pharmaceuticals, Whippany, NJ, USA
- 4Dept of Pulmonary and Critical Care Medicine, Respiratory Institute, Cleveland Clinic, Cleveland, OH, USA
- Corresponding author: Oisín Butler (oisin.butler{at}bayer.com)
Funding
Merck Sharp and Dohme
Bayer